Company Profile
Guangdong Hybribio Biotech develops, manufactures, and sells nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal, as well as STD real time PCR kits.
Its portfolio also includes hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits, hearing loss susceptibility genoarray diagnostic kits, COVID-19 real-time PCR kits, and devices/instruments
Including automated nucleic acid extraction, automatic medical PCR analysis, flow-through hybridization, auto DNA extraction, and fluorescent quantitative detection systems after-sales technical service support. Its products are used in the fields of national screening, clinical, and research purposes. The company operates in the Asia Pacific, the South East Asia, the Middle East, Europe, Africa, and South America. Founded in 2003, the company is based in Chaozhou, China.